Publications by authors named "E Perez-Persona"
Article Synopsis
- Infection is a major cause of death in multiple myeloma (MM), leading researchers to analyze immune profiles of MM patients compared to healthy individuals.
- The study found significant changes in the distribution of immune cell types in MM patients, particularly in B cells and T cells, which affected their response to COVID-19 vaccination.
- Results suggested that specific immune cell metrics, such as B-cell percentages and counts, can serve as biomarkers to tailor vaccination schedules for MM patients.
In this clinical trial, we demonstrate that ultrarapid fast infusion of rituximab (Truxima) in 30 min with oral premedication is feasible and secure for patients, and reduce the day-care hospital stays.
View Article and Find Full Text PDFBackground: Most patients with multiple myeloma (MM) relapse or become refractory, resulting in high health care costs. However, real-world data regarding the utilization of health care services among the relapsed/refractory MM (RRMM) population are scarce.
Methods: Observational, cross-sectional, multicenter study of the utilization of health care services by RRMM patients who had relapsed within the previous 6 months in Spain in a real-world setting.
Objectives: To describe the incorporation of monoclonal antibodies (mAb) in real-world (RW) practice for the treatment of patients with relapsed refractory multiple myeloma (RRMM) in a setting with other treatment alternatives.
Methods: This was an observational, multicenter, ambispective study of RRMM treated with or without a mAb.
Results: A total of 171 patients were included.
Urgent and unexpected findings are very common in oncology and haematology patients. This article reviews the most important points included in the European Society of Radiology's guidelines and proposes a practical approach to reporting and communicating these findings more efficiently. This approach is explained with illustrative examples.
View Article and Find Full Text PDF